15. Goodwill and Other Intangible Assets

expand table

reduce table

 

Goodwill

Trademarks

Patents

Capitalised development (in progress)

Capitalised development (completed)

Software

Other intangible assets

Total

in EUR thousand

               

Cost

               

Balance at 1 October 2007

120,537

27,846

15,099

3,055

13,621

21,108

24,814

226,080

Additions from acquisitions

3,544

639

4,183

Additions from internal development

696

696

Disposals

–63

–1,138

–1,201

Reclassifications

–3,055

3,055

65

–65

Other changes

139

139

Exchange differences

–89

63

–5

–31

Balance at 30 September 2008

120,385

27,846

15,099

17,372

23,781

25,383

229,866

Balance at 1 October 2008

120,385

27,846

15,099

17,372

23,781

25,383

229,866

Additions from acquisitions

3,696

21

3,717

Additions from internal development

643

643

Disposals

–330

–22,744

–23,074

Reclassifications

609

–464

145

Other changes

Exchange differences

39

–55

–18

–34

Balance at 30 September 2009

120,424

27,846

15,099

643

17,372

27,701

2,178

211,263


 

Goodwill

Trademarks

Patents

Capitalised development (in progress)

Capitalised development (completed)

Software

Other intangible assets

Total

in EUR thousand

               

Amortisation and Impairments

               

Balance at 1 October 2007

–85

–15,046

–2,872

–11,768

–20,540

–50,311

Amortisation

–5

–2,849

–3,292

–3,973

–10,119

Impairments

–2

–2

Disposals

217

217

Exchange differences

–32

2

–30

Balance at 30 September 2008

–85

–15,051

–5,721

–14,877

–24,511

–60,245

Balance at 1 October 2008

–85

–15,051

–5,721

–14,877

–24,511

–60,245

Amortisation

–4

–2,995

–3,293

–152

–6,444

Impairments

–5,967

–608

–6,575

Disposals

253

22,744

22,997

Exchange differences

15

20

35

Balance at 30 September 2009

–85

–15,055

–14,683

–18,510

–1,899

–50,232

                 

Carrying Amounts

               

Balance at 1 October 2007

120,537

27,761

53

3,055

10,749

9,340

4,274

175,769

Balance at 30 September 2008

120,385

27,761

48

11,651

8,904

872

169,621

Balance at 1 October 2008

120,385

27,761

48

11,651

8,904

872

169,621

Balance at 30 September 2009

120,424

27,761

44

643

2,689

9,191

279

161,031

Goodwill

The Group tests goodwill for impairment annually at segment level. Goodwill is allocated to segments as follows:

 

30 September

in EUR thousand

2009

2008

Industrial Cranes

15,525

15,486

Port Technology

8,266

8,266

Services

96,633

96,633

Total

120,424

120,385

As there is no active market in which to determine the fair value of the segments, the Group assesses goodwill allocated to them for impairment by reference to their discounted expected future operating cash flows less estimated costs to sell (fair value less costs to sell). These cash flows are estimated over the detailed planning period on the basis of the Group’s medium-term plan, which has a five-year planning horizon. Key factors incorporated into the planning model include trends in exchange rates, relevant markets, and costs of production, selling and marketing, and administration. These take into account general market forecasts alongside current trends and past experience. We refer to the Management Report for detailed information. For the ongoing future beyond the medium-term planning horizon, net cash flows are projected to remain unchanged and are not multiplied by a growth factor. The discount rate used to discount future cash flows is 12.6 percent in the Industrial Cranes and Services segments (2007/2008: 14.1 percent) and 8.8 percent in the Port Technology segment (2007/2008: 12.8 percent). This is equal to the weighted average pre-tax cost of capital.

As in the previous year, the impairment tests performed in financial year 2008/2009 confirmed the existing carrying amounts of goodwill.

Other Intangible Assets

The other intangible assets balance sheet item in the amount of EUR 40,606,000 (2008: EUR 49,236,000) comprises trademarks, patents, capitalised development costs for development in progress, capitalised development costs for completed development, software, and sundry other intangible assets.

EUR 643,000 in development expenses were capitalised for a new model range in financial year 2008/2009 (2007/2008: EUR 696,000). They were accounted for by the Port Technology segment.

Based on indications that they may be impaired, capitalised development expenses in the Port Technology segment were tested for impairment in financial year 2008/2009. The resulting impairment loss of EUR 5,967,000 was recognised in the Income Statement, where it is included in research and development expenses. The impairment loss is measured relative to the fair value determined using a net present value-based method with an after-tax discount rate of 7.5 percent. The impairment losses on other intangible assets related to the Port Technology segment in the amount of EUR 608,000 in financial year 2008/2009 and to the Industrial Cranes segment in the amount of EUR 2,000 in financial year 2007/2008.

As in the previous year, there were no impairment reversals in financial year 2008/2009.

Trademarks with indefinite useful lives are tested annually for impairment using the relief from royalty method. The recoverable amounts were computed by applying a pre-tax discount rate of 9.1 percent (2008: 9.8 percent) in the Industrial Cranes and Services segments and of 6.6 percent (2008: 9.0 percent) in the Port Technology segment. The imputed licence fee was 2.5 percent (2008: 2.5 percent). The carrying amounts of trademark assets in each segment are as follows:

 

30 September

in EUR thousand

2009

2008

Industrial Cranes

10,623

10,623

Port Technology

9,747

9,747

Services

6,891

6,891

Total

27,261

27,261

As in the previous year, impairment testing of trademarks did not give cause to recognise any impairment losses.

Amortisation and impairments of intangible assets are divided between items in the Income Statement as follows:

 

1 October to 30 September

in EUR thousand

2008/2009

Of which
impairments

2007/2008

Of which impairments

Cost of sales

–648

–5,249

Research and development expenses

–10,026

–6,575

–2,837

Selling, general and administrative expenses

–2,345

–2,035

–2

Total

–13,019

–6,575

–10,121

–2